[1]
“RELATIONSHIP BETWEEN VISFATIN AND SOME BIOMARKERS OF BONE TURNOVER IN PATIENTS WITH CHRONIC KIDNEY DISEASE”, mij, vol. 1, no. 3, pp. 31–36, Sep. 2022, doi: 10.35120/medisij010331p.